BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 146742)

  • 21. Differential effect of selenium supplementation on immunoglobulin levels in Down's syndrome.
    Magnusson CG; Nordvall SL; Annerén G
    Acta Paediatr; 1997 Dec; 86(12):1385-6. PubMed ID: 9475325
    [No Abstract]   [Full Text] [Related]  

  • 22. [Abnormal humoral and cellular immunity in ulcerative colitis and Crohn's disease].
    Asakura H; Tanaka T; Hibi T; Miura S; Mizuno Y; Oda Y; Tsuchiya M
    Nihon Rinsho; 1977 May; 35(5):1828-35. PubMed ID: 301952
    [No Abstract]   [Full Text] [Related]  

  • 23. T lymphocytes in patients with Down's syndrome.
    Wisniewski K; Cobill JM; Wilcox CB; Caspary EA; Williams DG; Wisniewski HM
    Biol Psychiatry; 1979 Jun; 14(3):463-71. PubMed ID: 157786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunological and purine enzyme studies on hyperuricaemic and normouricaemic patients with Down's syndrome.
    Watts RW; Perera YS; Allsop J; Newton C; Platts-Mills TA; Webster AD
    Clin Exp Immunol; 1979 Jun; 36(3):355-63. PubMed ID: 158448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Down's syndrome and hepatitis: an evaluation of carrier status.
    Dicks JL; Dennis ES
    J Am Dent Assoc; 1987 May; 114(5):637-9. PubMed ID: 2955013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunological features of Down's syndrome: a review.
    Nespoli L; Burgio GR; Ugazio AG; Maccario R
    J Intellect Disabil Res; 1993 Dec; 37 ( Pt 6)():543-51. PubMed ID: 8124000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell-mediated immunodeficiency in Down's syndrome: normal IL-2 production but inverted ratio of T cell subsets.
    Karttunen R; Nurmi T; Ilonen J; Surcel HM
    Clin Exp Immunol; 1984 Feb; 55(2):257-63. PubMed ID: 6230181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis B vaccination in Down's syndrome and other mentally retarded patients.
    Heijtink RA; De Jong P; Schalm SW; Masurel N
    Hepatology; 1984; 4(4):611-4. PubMed ID: 6235163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Physiopathology of rheumatoid psoriasis].
    Sany J; Clot J; Seignalet J; Guilhou JJ; Serre H
    Rev Rhum Mal Osteoartic; 1979 Oct; 46(10):551-60. PubMed ID: 317533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Humoral and cellular immunity in children with Down's syndrome].
    Lukas A; Cesarz E; Lukas W; Sychłowy A; Sliwa F
    Pediatr Pol; 1980 Jan; 55(1):33-40. PubMed ID: 6445054
    [No Abstract]   [Full Text] [Related]  

  • 31. [The immunological profile of children with Down's syndrome].
    Colombo ML; Girardo E; Saitta M; Ricci BM; Maina D
    Minerva Pediatr; 1989 Jan; 41(1):1-4. PubMed ID: 2525223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered cellular immune functions in patients with Down's syndrome.
    Spina CA; Smith D; Korn E; Fahey JL; Grossman HJ
    Am J Dis Child; 1981 Mar; 135(3):251-5. PubMed ID: 6452055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunologic aspect of tonsils.
    Morag A; Ogra PL
    Ann Otol Rhinol Laryngol; 1975; 84(2 PT2 SUPPL 19):37-43. PubMed ID: 1079438
    [No Abstract]   [Full Text] [Related]  

  • 34. [Hemoglobin concentration, hematocrit and leukocyte distribution pattern in children with Down's syndrome].
    Bartelik S
    Pediatr Pol; 1995 Jun; 70(6):467-71. PubMed ID: 8692603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T cell response to anti-CD3 antibody in Down's syndrome.
    Bertotto A; Arcangeli C; Crupi S; Marinelli I; Gerli R; Vaccaro R
    Arch Dis Child; 1987 Nov; 62(11):1148-51. PubMed ID: 2961309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Down's syndrome: problems of immunodeficiency.
    Ugazio AG
    Hum Genet Suppl; 1981; 2():33-9. PubMed ID: 6218139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [T- and B-lymphocytes, M, A and G immunoglobulins in viral hepatitis, liver cirrhosis and HBs-Ag carrier state].
    Belozerov ES; Sagandikov BB; Shabalin VV
    Klin Med (Mosk); 1979 Mar; 57(3):63-5. PubMed ID: 312361
    [No Abstract]   [Full Text] [Related]  

  • 38. Inhibition of Fc gamma receptors in the plasma of subjects with Down's syndrome.
    Guarnotta G; Giardina E; Casiglia D; Rossi C; Accardo-Palumbo A; Triolo G
    Clin Immunol Immunopathol; 1993 Oct; 69(1):92-6. PubMed ID: 8403547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunoregulatory CD4+ CD45R+ suppressor/inducer T lymphocyte subsets and impaired cell-mediated immunity in patients with Down's syndrome.
    Raziuddin S; Elawad ME
    Clin Exp Immunol; 1990 Jan; 79(1):67-71. PubMed ID: 1967994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HL-A frequencies in Down's syndrome.
    Segal DJ; Schlaut JW; Pabst HF; McCoy EE; Dossetor JB
    Humangenetik; 1975; 27(1):45-8. PubMed ID: 124700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.